Health in Marshall Islands, Republic of the 750 indicators covering health for Marshall Islands, Republic of the. IndicatorLatest Year10-yr change Rank Share of out of pocket expenditure on healthcare 1.05 2023 down 31.9% 191st Domestic general government health expenditure per capita 671.07 current US$ 2023 up 198.5% 64th Total official development assistance to medical research and basic 0.8762 million constant US$ 2024 up 516.8% 112th Tuberculosis treatment success rate in new and relapsed cases 92 2023 up 3.4% 35th Health spending per person by source 655.98 2023 up 222.1% 93rd Share of public expenditure on healthcare by country 75.05 2023 up 48.7% 36th Private health expenditure per person 17.64 2023 up 67.3% 188th Public healthcare spending share gdp 10.06 2023 up 64.2% 3rd Poliomyelitis - number of reported cases 0 2010 — 8th Rubella vaccination coverage 88 2024 up 11.4% 112th Mortality rate among children ages 10 to 14 years 2.75 2020 down 15.9% 56th Medical doctors 47 2021 up 42.4% 182nd People with basic handwashing facilities including soap and water 85.1% 2021 up 0.2% 45th Number of stillbirths 8 2023 down 52.9% 186th Mean systolic blood pressure 120.4 2015 up 1.1% 135th UHC Service Coverage sub-index on infectious diseases 79 2023 up 2.6% 129th UHC Service Coverage sub-index on service capacity and access 75 2023 up 5.6% 98th UHC Service Coverage sub-index on reproductive, maternal, newborn and 71 2023 up 4.4% 103rd UHC Service Coverage Index 66 2023 up 1.5% 124th UHC Service Coverage sub-index on noncommunicable diseases 46 2023 down 4.2% 178th Stillbirth rate 9.98 2023 down 20.4% 75th Maternal mortality ratio 154.79 per 100,000 live births 2023 down 22.9% 45th Universal health coverage (UHC) service coverage index, 2025 66 index 2023 up 1.5% 116th Hepb3 number unvaccinated 92.73 2023 down 65.4% 174th Rotavirus vaccines completed dose (RotaC) immunization coverage among 44.0% 2025 up 7.3% 123rd Tb related deaths hiv 0 2023 — 158th Smoking bans in public places 8 2022 unchanged 1st Current health expenditure (CHE) as percentage of gross domestic 13.4% 2023 up 10.5% 5th External health expenditure (EXT) as percentage of current health 22.9% 2023 down 51.1% 30th Domestic general government health expenditure (GGHE-D) as percentage 75.0% 2023 up 48.7% 36th Out-of-pocket expenditure as percentage of current health expenditure 1.1% 2023 down 31.9% 190th Domestic general government health expenditure (GGHE-D) as percentage 10.1% 2023 up 64.2% 3rd Domestic general government health expenditure (GGHE-D) as percentage 15.2% 2023 up 37.7% 42nd Domestic private health expenditure (PVT-D) as percentage of current 2.0% 2023 down 22.8% 191st Current health expenditure (CHE) per capita in US$ 894.22 2023 up 100.8% 67th Domestic private health expenditure (PVT-D) per capita in US$ 18.04 2023 up 55.0% 168th Domestic general government health expenditure (GGHE-D) per capita in 671.07 2023 up 198.5% 64th Total healthcare expenditure gdp 13.41 2023 up 10.5% 5th Health expenditure government expenditure 15.24 2023 up 37.7% 42nd Mumps - number of reported cases 0 2025 down 100.0% 109th Incidence of tuberculosis (per 100 000 population) 0 2023 down 100.0% 174th Hib vaccine 72 2024 up 10.8% 159th Congenital Rubella Syndrome - number of reported cases 0 2025 — 16th External health expenditure (EXT) per capita in US$ 205.1 2023 down 1.8% 5th Dentists 6 2021 up 50.0% 170th People with basic handwashing facilities including soap and water 80.2% 2021 unchanged 41st Nursing and midwifery personnel 199 2021 up 2.1% 184th Nursing personnel 199 2021 up 2.1% 183rd Raised blood pressure (SBP>=140 OR DBP>=90) 27.19 2019 up 6.2% 131st Raised blood pressure (SBP>=140 OR DBP>=90) 25.65 2019 up 5.3% 136th Hypertension: diagnosis coverage among adults aged 30-79 with 45.5% 2019 up 6.6% 135th Hypertension among adults aged 30-79 years, prevalence 31.9 2019 up 6.3% 146th Hypertension effective treatment coverage (controlled hypertension) 14.7% 2019 unchanged 112th Hypertension: effective treatment coverage (controlled hypertension) 14.5% 2019 up 0.7% 111th Hypertension treatment coverage among adults aged 30-79 with 29.8% 2019 down 5.1% 132nd Hypertension treatment coverage among adults aged 30-79 with 30.3% 2019 down 7.3% 134th Hypertension: diagnosis coverage among adults aged 30-79 with 45.1% 2019 up 8.2% 130th Hypertension among adults aged 30-79 years, prevalence, crude 30 2019 up 5.3% 161st Pneumococcal conjugate second or third-dose vaccines (PCVc) 62.0% 2025 down 17.3% 142nd People with basic handwashing facilities including soap and water 86.4% 2021 unchanged 44th ← Previous Page 9 of 13 Next →